SEC Form 4 · accession 0001214659-16-015272
Anthera Pharmaceuticals Inc · ANTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David E. Thompson
Director
Period of report
Dec 8, 2016
Accepted (ET)
Dec 8, 2016 · 6:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001316175
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.00 | Dec 8, 2016 | A | 83,910 | A | — | Dec 8, 2026 | Common Stock | 83,910 | 83,910 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable in 12 equal monthly installments from the vesting commencement date of December 8, 2016. This stock option is fully exercisable on December 8, 2017.